(Q24657681)
Statements
Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders (English)
0 references
15 June 2008
0 references
111
0 references
12
0 references
5663-71
0 references
1 reference
1 reference